Ma, Jie
Liu, Cuizhen
Laoguo, Shi-xue
Zhou, Huafu
Wang, Yongyong
Guo, Jianji
Yang, Lihua
Tang, Jing
Li, Rong
Zeng, Zhiming
Dai, Lei
Mo, Ning
Zeng, Jie
Clinical trials referenced in this document:
Documents that mention this clinical trial
Anlotinib hydrochloride combined with tislelizumab, paclitaxel liposome, and nedaplatin regimen for preoperative neoadjuvant therapy of esophageal cancer: A single-arm, single-center, phase II exploratory clinical study.
https://doi.org/10.1200/jco.2023.41.16_suppl.e16082
Funding for this research was provided by:
None.
Publication History
Published: 2023-05-31